ECN-137 was reported by Nakashima et al. The compounds had tetracyclic skeletons, which mimicked the core structure of purpactin A. They were examined for their activity on transforming growth factor-β1 (TGF-β1) induced wound closure of MDA-MB-231 breast cancer cells [16]. The gene discussed is TGFB1; the disease is breast cancer.